The AIDS incubation period in the UK estimated from a national register of HIV seroconverters

AIDS

Volumn 12, Issue 6, 1998, Pages 659-667

  Porter, Kholoud ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

HIV; Incubation period; Late entry; Progression estimates; Seroconverters; Survival analysis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; DISEASE COURSE; ETHNIC GROUP; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROBABILITY; SEROCONVERSION; SURVIVAL; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; TIME FACTORS;

EID: 6844261153     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Goedert JJ, Biggar RJ, Weiss SH, et al.: Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986, 231:992-995.
2. Lui K-J, Lawrence DN, Morgan WM, Peterman TA, Haverkos HW, Bregman DJ: A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc Natl Acad Sci USA 1986, 83:3051-3055.
3. Taylor JMC, Schwartz K, Detels R: The time from infection with human immunodeficiency virus (HIV) to the onset of AIDS. J Infect Dis 1986, 154:694-697.
4. Medley GF, Anderson RM, Cox DR, Billard L: Incubation period of AIDS in patients infected via blood transfusion. Nature 1987, 328:719-721.
5. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ: Natural history of human immunodeficiency virus infections in haemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987, 107:1-6.
6. Giesecke J, Scalia-Tomba G, Berglund O, Berntorp E, Schulman S, Stigendal L: Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ 1988, 297:99-103.
7. Schechter MT, Craib KJP, Le TN, et al.: Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989, 3:347-353.
8. Muñoz A, Wang M-C, Bass S, et al.: Acquired immune deficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 seroconversion in homosexual men. Am J Epidemiol 1989, 130:530-539.
9. Jason J, Lui K-J, Ragni MV, Hessol NA, Darrow WW: Risk of developing AIDS in HIV-infected cohorts of haemophiliac and homosexual men. JAMA 1989, 261:725-727.
10. Moss AR, Bacchetti P: Natural history of HIV infection. AIDS 1989, 3:55-61.
11. Darby SC, Rizza CR, Doll R, Spooner RJD, Stratton IM, Thakrar B: Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ 1989, 298:1064-1068.
12. Hessol NA, Lifson AR, O'Malley PM, Doll LS, Jaffe HW, Rutherford GW: Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol 1989, 130:1167-1175.
13. Goedert JJ, Kessler CM, Aledort LM, et al.: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with haemophilia. N Engl J Med 1989, 321:1141-1148.
14. Ward JW, Bush TJ, Perkins HA, et al.: The natural history of transfusion-associated infection with human immunodeficiency virus. N Engl J Med 1989, 321:947-952.
15. Rezza G, Lazzarin A, Angarano G, et al.: The natural history of HIV infection in injecting drug users: risk of disease progression in a cohort of seroconverters. AIDS 1989, 3:87-90.
16. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza, CR: Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation. Lancet 1996, 347:1573-1579.
17. Boufassa F, Carre N, Deveau C, et al.: HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1). Hematol Cell Ther 1996, 38:193 198.
18. Spijkerman IJ, Langendam MW, Veugelers-PJ, et al.: Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion. Epidemiology 1996, 7:571-577.
19. Pezzotti P, Phillips AN, Dorrucci M, et al.: Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ 1996, 313:585-586.
20. Brettle RP, McNeil AJ, Burns S, et al.: Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996, 10:419-430.
21. Morgan D, Maude GH, Malamba SS, et al.: HIV-1 disease progression and AIDS-defining disorders in rural Uganda, Lancet 1997, 350:245-250.
22. Eskild A, Magnus P, Brekke T, et al.: The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects. Scand J Infect Dis 1997, 29:103-109.
23. Sinicco A, Fora R, Raiteri R, et al.: Is the clinical course of HIV-1 changing? Cohort study. BMJ 1997, 314:1232-1237.
24. Prins M, Veugelers PJ, European Seroconverter Study and the Triontinental Seroconverter Study: Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. AIDS 1997, 11:621-631
25. Begtrup K, Melbye M, Biggar RJ, Goedert JJ, Knudsen K, Andersen PK: Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion. Am J Epidemiol 1997, 145:629-635.
26. US Department of Health and Human Services: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus MMWR 1989, 38 (suppl 5):1-9.
27. Volberding PA, Lagakos SW, Grimes JM, et al.: The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group JAMA 1994, 272:437 442.
28. Delta Co-ordinating Committee: Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine with zidovudine alone in HIV-infected individuals. Lancet 1996, 348:283-291.
29. Lee CA, Phillips AN, Elford J, et al.: Progression of HIV disease in a haemophiliac cohort followed for eleven years and the effect of treatment. BMJ 1991, 303:1093-1096.
30. Ragni MV, Kingsley LA: Cumulative risk for AIDS and other HIV outcomes in a cohort of haemophiliacs in Western Pennsylvania. J Acquir Immune Defic Syndr 1990, 3:708-713.
31. Msellati P, Dupon M, Morlat P, Lacoste D, Pellegrin I, Dabis F: A cohort study of 89 HIV-1 infected adult patients contaminated by blood products: Bordeaux 1981-1989. AIDS 1990, 4:1105-1109.
32. Phillips AN, Lee CA, Elford J, et al.: More rapid progression to AIDS in older HIV infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr 1991, 4:970-975.
33. Carré N, Deveau C, Belanger F, et al.: Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994, 8:797-802.
34. Schinaia N, Ghirardini A, Chiarotti F, Gringeri A, Mannucci PM, the Italian Group: Progression to AIDS among Italian HIV-seropositive haemophiliacs. AIDS 1991, 5:385-391.
35. Blaxhult A, Fredrik G, Lidman K, Giesecke J: The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990, 4:123-129.
36. Operskalski EA, Stram DO, Lee H, et al.: Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis 1995, 172:648-655.
37. Brettle RP, McNeil AJ, Gore SM, Bird AG, Leen CS, Richardson A: The Edinburgh City Hospital cohort: analysis of enrolment, progression and mortality by baseline covariates. Q J Med 1995, 88:479-491.
38. Pehrson P-O, Lindbäck S, Lindman C, Gaines H, Giesecke J: Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology. AIDS 1997, 11:1007-1012.
39. UK Register of HIV Seroconverters Steering Committee: The UK Register of HIV-seroconverters. methods and analytical issues. Epidemiol Infect 1996, 117:305-312.
40. Molesworth AM: Results from the 1995 survey of prevalent clinically diagnosed HIV infections in England, Wales, and Northern Ireland. Comm Dis Rep 1997, 7(6):R77-82.
41. Clayton C, Hills M: Statistical Models in Epidemiology. Oxford: Oxford University Press; 1995.
42. Centres tor Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36:1S.
43. Ancelle-Park RA: European AIDS definition. Lancet 1992, 339:671.
44. Biggar RJ: AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 1990, 4: 1059-1066.
45. KUO J-M, Taylor JMG, Delels R: Estimating the AIDS incubation period from a prevalent cohort. Am J Epidemiol 1991, 133:1050-1057.
46. Phair J, Jacobson L, Detels R, et al.: Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992, 5:490-496.
47. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 1994, 8:112-1128.
48. Hessol NA, Koblin BA, van Griensven GJP, et al.: Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1976-1991. Am J Epidemiol 1994, 139:1077-1087.
49. Veugelers PJ, Page KA, Tindall B, et al.: Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Lpidemiol 1994, 140:747-758.
50. Hogg RS, Strathdee SA, Craib KJP, O'Shaughnessy MV, Montaner JSG, Schechter MT: Lower socioeconomic status and shorter survival following HIV infection, Lancet 1994, 344:1120-1124.
51. Beral V, Peterman V, Berkelman RL, Jaffe HW: Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990, 335:123-128.
52. Crowe SM, Carlin JB, Stewart KI, Luca CR, Hoy JF: Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991, 4:770-776.
53. Rosenberg PS, Goedert JJ, Biggar RJ, Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters: Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994, 8:803-810.
54. Keel IPM, Veugelers PJ, Koot M, et al.: Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993 [letter]. AIDS 1996, 10:1601-1602.